| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberous Sclerosis | 130 | 2023 | 1029 | 14.160 |
Why?
|
| Tumor Suppressor Proteins | 132 | 2023 | 2849 | 7.970 |
Why?
|
| Lymphangioleiomyomatosis | 29 | 2022 | 210 | 6.620 |
Why?
|
| Angiomyolipoma | 21 | 2023 | 190 | 5.800 |
Why?
|
| TOR Serine-Threonine Kinases | 64 | 2022 | 2109 | 4.130 |
Why?
|
| Kidney Neoplasms | 42 | 2023 | 4262 | 3.270 |
Why?
|
| Gelsolin | 52 | 2005 | 190 | 2.990 |
Why?
|
| Mosaicism | 16 | 2022 | 441 | 2.990 |
Why?
|
| Chromosomes, Human, Pair 9 | 42 | 2000 | 535 | 2.870 |
Why?
|
| Sirolimus | 33 | 2023 | 1564 | 2.550 |
Why?
|
| Mutation | 100 | 2023 | 29786 | 2.530 |
Why?
|
| Lung Neoplasms | 68 | 2024 | 13102 | 2.430 |
Why?
|
| Microfilament Proteins | 44 | 2011 | 1152 | 1.910 |
Why?
|
| Repressor Proteins | 35 | 2015 | 3023 | 1.890 |
Why?
|
| Urinary Bladder Neoplasms | 17 | 2022 | 2245 | 1.860 |
Why?
|
| Urologic Neoplasms | 5 | 2019 | 318 | 1.780 |
Why?
|
| Protein Kinases | 20 | 2014 | 1640 | 1.740 |
Why?
|
| Polymorphism, Genetic | 46 | 2005 | 4328 | 1.680 |
Why?
|
| Carcinoma, Renal Cell | 17 | 2023 | 3143 | 1.680 |
Why?
|
| Multiprotein Complexes | 25 | 2016 | 1119 | 1.660 |
Why?
|
| Proteins | 43 | 2015 | 6103 | 1.570 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 22 | 2024 | 5221 | 1.410 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 20 | 2005 | 798 | 1.320 |
Why?
|
| Malaria, Cerebral | 13 | 2003 | 135 | 1.280 |
Why?
|
| Phosphatidylinositol 3-Kinases | 18 | 2023 | 2938 | 1.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 20 | 2023 | 2503 | 1.180 |
Why?
|
| Signal Transduction | 64 | 2021 | 23403 | 1.160 |
Why?
|
| Angiofibroma | 4 | 2021 | 68 | 1.150 |
Why?
|
| Ribosomal Protein S6 Kinases | 13 | 2011 | 205 | 1.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 27 | 2005 | 4420 | 1.060 |
Why?
|
| Protein Kinase Inhibitors | 15 | 2023 | 5535 | 0.990 |
Why?
|
| Chromosome Mapping | 39 | 2013 | 4740 | 0.960 |
Why?
|
| DNA Mutational Analysis | 31 | 2018 | 4186 | 0.950 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 6 | 2021 | 75 | 0.930 |
Why?
|
| Disease Models, Animal | 34 | 2021 | 18029 | 0.900 |
Why?
|
| Facial Neoplasms | 2 | 2022 | 121 | 0.890 |
Why?
|
| Humans | 418 | 2024 | 744343 | 0.880 |
Why?
|
| Loss of Heterozygosity | 11 | 2016 | 684 | 0.880 |
Why?
|
| Gene Amplification | 6 | 2021 | 1063 | 0.880 |
Why?
|
| Mice | 139 | 2021 | 81183 | 0.860 |
Why?
|
| Contractile Proteins | 15 | 2006 | 246 | 0.840 |
Why?
|
| Cystadenoma | 7 | 2014 | 84 | 0.820 |
Why?
|
| Actins | 29 | 2006 | 2121 | 0.810 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2021 | 705 | 0.800 |
Why?
|
| Up-Regulation | 12 | 2021 | 4217 | 0.800 |
Why?
|
| Malaria, Falciparum | 13 | 2005 | 1077 | 0.780 |
Why?
|
| Polymerase Chain Reaction | 33 | 2014 | 6171 | 0.780 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 2 | 2020 | 252 | 0.780 |
Why?
|
| Animals | 192 | 2021 | 168757 | 0.770 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2020 | 32 | 0.770 |
Why?
|
| Germ-Line Mutation | 9 | 2022 | 1788 | 0.770 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2020 | 37 | 0.770 |
Why?
|
| Tumor Suppressor Protein p53 | 7 | 2024 | 2948 | 0.750 |
Why?
|
| Calcium-Binding Proteins | 19 | 2009 | 1081 | 0.740 |
Why?
|
| Genes, Tumor Suppressor | 13 | 2022 | 1097 | 0.730 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2021 | 434 | 0.720 |
Why?
|
| Seizures | 10 | 2022 | 2859 | 0.720 |
Why?
|
| Astrocytoma | 2 | 2020 | 790 | 0.710 |
Why?
|
| Gene Expression Regulation, Neoplastic | 17 | 2021 | 8428 | 0.710 |
Why?
|
| Alleles | 35 | 2016 | 6933 | 0.700 |
Why?
|
| COUP Transcription Factor II | 1 | 2019 | 18 | 0.700 |
Why?
|
| Retroperitoneal Neoplasms | 3 | 2019 | 340 | 0.690 |
Why?
|
| Antineoplastic Agents | 11 | 2021 | 13695 | 0.690 |
Why?
|
| Neoplasms | 16 | 2023 | 21683 | 0.670 |
Why?
|
| Antibiotics, Antineoplastic | 10 | 2021 | 692 | 0.660 |
Why?
|
| Base Sequence | 53 | 2019 | 12797 | 0.660 |
Why?
|
| Promoter Regions, Genetic | 19 | 2017 | 5867 | 0.660 |
Why?
|
| Benzoxazoles | 3 | 2022 | 77 | 0.660 |
Why?
|
| Cell Line, Tumor | 26 | 2023 | 16689 | 0.650 |
Why?
|
| Liver Neoplasms | 7 | 2023 | 4253 | 0.650 |
Why?
|
| rac1 GTP-Binding Protein | 5 | 2008 | 237 | 0.650 |
Why?
|
| Hemangiopericytoma | 1 | 2018 | 77 | 0.650 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2020 | 320 | 0.640 |
Why?
|
| Hamartoma | 4 | 2009 | 238 | 0.640 |
Why?
|
| Epilepsy | 10 | 2023 | 3310 | 0.630 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2023 | 377 | 0.610 |
Why?
|
| Monomeric GTP-Binding Proteins | 6 | 2016 | 199 | 0.600 |
Why?
|
| Genotype | 38 | 2021 | 12951 | 0.590 |
Why?
|
| Interferon-gamma | 9 | 2005 | 3206 | 0.590 |
Why?
|
| Transcription Factors | 19 | 2023 | 12208 | 0.590 |
Why?
|
| Molecular Sequence Data | 59 | 2014 | 18111 | 0.580 |
Why?
|
| Glutathione | 1 | 2019 | 589 | 0.580 |
Why?
|
| Genetic Linkage | 23 | 2006 | 2421 | 0.570 |
Why?
|
| Gambia | 26 | 2005 | 98 | 0.570 |
Why?
|
| Platelet-Derived Growth Factor | 4 | 2006 | 625 | 0.560 |
Why?
|
| Polymorphism, Single Nucleotide | 24 | 2019 | 15519 | 0.560 |
Why?
|
| DNA, Neoplasm | 3 | 2017 | 1758 | 0.550 |
Why?
|
| Genetic Predisposition to Disease | 32 | 2022 | 17446 | 0.550 |
Why?
|
| Proto-Oncogene Proteins | 11 | 2022 | 4554 | 0.540 |
Why?
|
| Mesothelioma | 3 | 2023 | 818 | 0.540 |
Why?
|
| Vigabatrin | 5 | 2023 | 92 | 0.540 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 671 | 0.540 |
Why?
|
| Female | 169 | 2023 | 380194 | 0.540 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2019 | 808 | 0.530 |
Why?
|
| Sequence Deletion | 9 | 2010 | 1526 | 0.530 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 9 | 2022 | 1692 | 0.530 |
Why?
|
| Fibroblasts | 15 | 2021 | 4161 | 0.530 |
Why?
|
| Introns | 5 | 2015 | 991 | 0.530 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2019 | 604 | 0.520 |
Why?
|
| Phenotype | 33 | 2023 | 16365 | 0.520 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2023 | 990 | 0.520 |
Why?
|
| Urothelium | 2 | 2019 | 277 | 0.520 |
Why?
|
| Male | 150 | 2023 | 350118 | 0.520 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2007 | 180 | 0.510 |
Why?
|
| Carrier Proteins | 18 | 2014 | 5021 | 0.510 |
Why?
|
| Melanins | 1 | 2016 | 289 | 0.500 |
Why?
|
| Skin Pigmentation | 1 | 2016 | 282 | 0.490 |
Why?
|
| Neurons | 22 | 2021 | 9338 | 0.490 |
Why?
|
| Gene Deletion | 10 | 2011 | 2751 | 0.490 |
Why?
|
| NF-kappa B | 10 | 2015 | 2499 | 0.490 |
Why?
|
| Cell Movement | 16 | 2019 | 5217 | 0.490 |
Why?
|
| Forkhead Transcription Factors | 3 | 2023 | 1613 | 0.480 |
Why?
|
| Gene Frequency | 27 | 2006 | 3588 | 0.480 |
Why?
|
| Genetic Variation | 21 | 2018 | 6544 | 0.470 |
Why?
|
| Giant Cells | 1 | 2014 | 187 | 0.470 |
Why?
|
| Cell Proliferation | 20 | 2023 | 10481 | 0.470 |
Why?
|
| Heart Neoplasms | 3 | 2006 | 374 | 0.470 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 365 | 0.460 |
Why?
|
| Molecular Targeted Therapy | 9 | 2018 | 2727 | 0.460 |
Why?
|
| Pyrimidines | 6 | 2022 | 2942 | 0.460 |
Why?
|
| Child, Preschool | 49 | 2023 | 41006 | 0.450 |
Why?
|
| Melanocytes | 1 | 2016 | 515 | 0.450 |
Why?
|
| Immunohistochemistry | 24 | 2021 | 11366 | 0.440 |
Why?
|
| Ligase Chain Reaction | 2 | 2010 | 8 | 0.440 |
Why?
|
| C-Reactive Protein | 9 | 2009 | 3778 | 0.440 |
Why?
|
| Neuropeptides | 6 | 2016 | 942 | 0.430 |
Why?
|
| Haplotypes | 21 | 2009 | 2779 | 0.430 |
Why?
|
| Linkage Disequilibrium | 11 | 2005 | 1997 | 0.430 |
Why?
|
| Malaria | 14 | 2005 | 1239 | 0.430 |
Why?
|
| Phosphorylation | 20 | 2013 | 8436 | 0.420 |
Why?
|
| Chylothorax | 2 | 2009 | 84 | 0.410 |
Why?
|
| Ventricular Septum | 2 | 2022 | 73 | 0.410 |
Why?
|
| DNA | 24 | 2020 | 7301 | 0.410 |
Why?
|
| Mice, Knockout | 43 | 2017 | 14557 | 0.410 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2015 | 2942 | 0.410 |
Why?
|
| Middle Aged | 78 | 2022 | 213383 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-met | 5 | 2020 | 578 | 0.400 |
Why?
|
| Infant | 39 | 2023 | 35136 | 0.400 |
Why?
|
| High-Throughput Nucleotide Sequencing | 12 | 2021 | 3597 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 33 | 2021 | 21827 | 0.390 |
Why?
|
| Hemangioma | 4 | 2009 | 738 | 0.390 |
Why?
|
| Plasmodium falciparum | 17 | 2001 | 1732 | 0.390 |
Why?
|
| Pulmonary Atresia | 2 | 2022 | 160 | 0.390 |
Why?
|
| Quinazolines | 4 | 2014 | 1356 | 0.390 |
Why?
|
| DNA Probes | 5 | 2007 | 560 | 0.390 |
Why?
|
| Heterozygote | 16 | 2008 | 2804 | 0.380 |
Why?
|
| Sequence Analysis | 2 | 2010 | 256 | 0.380 |
Why?
|
| Adult | 80 | 2022 | 214055 | 0.380 |
Why?
|
| Cells, Cultured | 36 | 2019 | 19229 | 0.370 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2021 | 3557 | 0.370 |
Why?
|
| Apoptosis | 17 | 2023 | 9727 | 0.370 |
Why?
|
| Nuclear Proteins | 8 | 2020 | 5853 | 0.360 |
Why?
|
| Heptanoic Acids | 2 | 2009 | 343 | 0.360 |
Why?
|
| Molecular Probe Techniques | 2 | 2008 | 119 | 0.360 |
Why?
|
| Interleukin-8 | 3 | 2004 | 690 | 0.360 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2009 | 437 | 0.360 |
Why?
|
| GTP-Binding Proteins | 4 | 1999 | 970 | 0.360 |
Why?
|
| Immunotherapy | 3 | 2023 | 4445 | 0.360 |
Why?
|
| DNA-Binding Proteins | 13 | 2020 | 9648 | 0.350 |
Why?
|
| Rhabdomyoma | 3 | 2005 | 57 | 0.350 |
Why?
|
| Adenocarcinoma | 10 | 2018 | 6364 | 0.350 |
Why?
|
| Endotoxemia | 1 | 2010 | 207 | 0.340 |
Why?
|
| Gene Expression Profiling | 13 | 2019 | 9438 | 0.340 |
Why?
|
| Stem Cells | 5 | 2017 | 3567 | 0.340 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2023 | 5172 | 0.340 |
Why?
|
| Neoplasm Invasiveness | 3 | 2020 | 3616 | 0.340 |
Why?
|
| Immunoenzyme Techniques | 8 | 2013 | 1799 | 0.340 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2009 | 101 | 0.330 |
Why?
|
| Nitric Oxide Synthase | 4 | 2000 | 916 | 0.330 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2022 | 2455 | 0.330 |
Why?
|
| Respiratory Syncytial Virus Infections | 3 | 2004 | 329 | 0.320 |
Why?
|
| Naphthyridines | 3 | 2021 | 118 | 0.320 |
Why?
|
| Genomics | 8 | 2020 | 5720 | 0.320 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 2 | 2020 | 105 | 0.320 |
Why?
|
| Oncogene Protein v-akt | 1 | 2008 | 135 | 0.320 |
Why?
|
| Mice, Nude | 8 | 2021 | 3689 | 0.320 |
Why?
|
| Brain Neoplasms | 4 | 2020 | 8863 | 0.310 |
Why?
|
| Cell Line | 31 | 2014 | 15997 | 0.300 |
Why?
|
| Nucleotides | 3 | 2022 | 464 | 0.300 |
Why?
|
| Tumor Microenvironment | 7 | 2024 | 3586 | 0.300 |
Why?
|
| Boronic Acids | 1 | 2012 | 965 | 0.300 |
Why?
|
| Child | 62 | 2022 | 77709 | 0.300 |
Why?
|
| Chromosome Deletion | 6 | 2014 | 1401 | 0.300 |
Why?
|
| DNA Primers | 14 | 2008 | 2892 | 0.300 |
Why?
|
| Mice, Transgenic | 17 | 2021 | 9734 | 0.300 |
Why?
|
| Peritoneal Neoplasms | 1 | 2013 | 665 | 0.300 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 5 | 1999 | 335 | 0.300 |
Why?
|
| Chemotaxis | 2 | 2006 | 607 | 0.300 |
Why?
|
| Dermatomyositis | 2 | 2019 | 224 | 0.290 |
Why?
|
| TRPP Cation Channels | 1 | 2007 | 176 | 0.290 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2009 | 472 | 0.290 |
Why?
|
| Cytokines | 5 | 2010 | 7322 | 0.290 |
Why?
|
| Carcinoma | 3 | 2019 | 2375 | 0.290 |
Why?
|
| Aged | 49 | 2022 | 163280 | 0.290 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2010 | 1572 | 0.290 |
Why?
|
| DNA, Complementary | 6 | 2000 | 2050 | 0.280 |
Why?
|
| Gene Expression Regulation | 14 | 2019 | 12072 | 0.280 |
Why?
|
| Dystonia Musculorum Deformans | 6 | 1992 | 158 | 0.280 |
Why?
|
| Oligodeoxyribonucleotides | 12 | 1993 | 708 | 0.280 |
Why?
|
| Tumor Cells, Cultured | 13 | 2019 | 6314 | 0.280 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 5 | 2000 | 127 | 0.280 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 6 | 2022 | 1660 | 0.280 |
Why?
|
| Prognosis | 24 | 2023 | 29063 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2010 | 480 | 0.270 |
Why?
|
| ras Proteins | 2 | 2014 | 1060 | 0.270 |
Why?
|
| Atherosclerosis | 3 | 2007 | 3445 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2021 | 648 | 0.270 |
Why?
|
| Pyrazines | 1 | 2012 | 1230 | 0.270 |
Why?
|
| STAT3 Transcription Factor | 6 | 2015 | 873 | 0.270 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2005 | 63 | 0.270 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 3523 | 0.270 |
Why?
|
| Embryo, Mammalian | 6 | 2009 | 1701 | 0.270 |
Why?
|
| Aged, 80 and over | 20 | 2021 | 57776 | 0.270 |
Why?
|
| Pyrroles | 2 | 2009 | 1146 | 0.260 |
Why?
|
| Autophagy | 6 | 2021 | 1300 | 0.260 |
Why?
|
| Gene Dosage | 3 | 2020 | 1252 | 0.260 |
Why?
|
| Receptor, Notch1 | 2 | 2019 | 502 | 0.260 |
Why?
|
| Drosophila Proteins | 3 | 2003 | 1703 | 0.260 |
Why?
|
| Cloning, Molecular | 13 | 2000 | 4320 | 0.260 |
Why?
|
| GTPase-Activating Proteins | 3 | 2015 | 498 | 0.250 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2019 | 388 | 0.250 |
Why?
|
| Interleukin-10 | 3 | 2005 | 1200 | 0.250 |
Why?
|
| Exanthema | 2 | 2019 | 501 | 0.250 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2004 | 44 | 0.250 |
Why?
|
| DNA Copy Number Variations | 5 | 2018 | 1941 | 0.250 |
Why?
|
| Metformin | 1 | 2012 | 835 | 0.250 |
Why?
|
| Trans-Activators | 5 | 2008 | 2924 | 0.250 |
Why?
|
| Neutrophils | 7 | 2019 | 3719 | 0.250 |
Why?
|
| Artemisinins | 2 | 1997 | 221 | 0.250 |
Why?
|
| Pathology, Molecular | 2 | 2018 | 326 | 0.250 |
Why?
|
| Demyelinating Diseases | 1 | 2007 | 354 | 0.250 |
Why?
|
| Exons | 10 | 2019 | 2437 | 0.250 |
Why?
|
| Bronchiolitis, Viral | 2 | 2004 | 74 | 0.240 |
Why?
|
| Immunoblotting | 8 | 2018 | 1682 | 0.240 |
Why?
|
| Transgenes | 2 | 2007 | 1009 | 0.240 |
Why?
|
| Blood Platelets | 7 | 2001 | 2508 | 0.240 |
Why?
|
| Epidermal Growth Factor | 2 | 2005 | 708 | 0.240 |
Why?
|
| Brain | 21 | 2022 | 26385 | 0.240 |
Why?
|
| Malformations of Cortical Development | 2 | 2017 | 200 | 0.240 |
Why?
|
| Pinocytosis | 2 | 2021 | 65 | 0.240 |
Why?
|
| Nucleic Acid Hybridization | 6 | 1999 | 1375 | 0.240 |
Why?
|
| Oncogene Proteins | 3 | 2020 | 749 | 0.240 |
Why?
|
| Muscle Cells | 1 | 2004 | 197 | 0.230 |
Why?
|
| Integrases | 4 | 2018 | 533 | 0.230 |
Why?
|
| Cardiomegaly | 3 | 2014 | 620 | 0.230 |
Why?
|
| Lateral Ventricles | 1 | 2004 | 146 | 0.230 |
Why?
|
| Immunity, Innate | 5 | 2006 | 2958 | 0.230 |
Why?
|
| Lipopolysaccharides | 6 | 2010 | 2216 | 0.230 |
Why?
|
| Genetic Markers | 19 | 2012 | 2634 | 0.230 |
Why?
|
| Neoplasm Metastasis | 6 | 2021 | 4851 | 0.230 |
Why?
|
| Homozygote | 4 | 2007 | 1785 | 0.230 |
Why?
|
| Neoplasm Staging | 11 | 2021 | 11031 | 0.230 |
Why?
|
| Vascular Endothelial Growth Factor D | 2 | 2021 | 63 | 0.230 |
Why?
|
| Survival Analysis | 12 | 2019 | 10252 | 0.220 |
Why?
|
| Epithelioid Cells | 2 | 2016 | 71 | 0.220 |
Why?
|
| Macrophages | 10 | 2023 | 5655 | 0.220 |
Why?
|
| Anticonvulsants | 4 | 2021 | 1916 | 0.220 |
Why?
|
| Estradiol | 2 | 2014 | 2020 | 0.220 |
Why?
|
| Cell Size | 7 | 2011 | 643 | 0.220 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2008 | 323 | 0.220 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2003 | 111 | 0.220 |
Why?
|
| Case-Control Studies | 22 | 2019 | 21746 | 0.220 |
Why?
|
| Cell Division | 11 | 2008 | 4568 | 0.220 |
Why?
|
| Genome, Human | 9 | 2018 | 4420 | 0.210 |
Why?
|
| Contactins | 1 | 2022 | 21 | 0.210 |
Why?
|
| Cell Cycle Proteins | 8 | 2014 | 3462 | 0.210 |
Why?
|
| Quinine | 4 | 1997 | 54 | 0.210 |
Why?
|
| Drug Synergism | 4 | 2021 | 1792 | 0.210 |
Why?
|
| Adolescent | 32 | 2022 | 85781 | 0.210 |
Why?
|
| Caspases | 4 | 2004 | 928 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 15 | 2010 | 6386 | 0.210 |
Why?
|
| Kidney | 8 | 2014 | 7186 | 0.200 |
Why?
|
| Immunosuppressive Agents | 5 | 2015 | 4149 | 0.200 |
Why?
|
| Survival Rate | 11 | 2021 | 12788 | 0.200 |
Why?
|
| Sesquiterpenes | 4 | 2009 | 177 | 0.200 |
Why?
|
| Amino Acid Sequence | 23 | 2012 | 13815 | 0.200 |
Why?
|
| Ritanserin | 1 | 2021 | 9 | 0.200 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2021 | 135 | 0.200 |
Why?
|
| Nail-Patella Syndrome | 3 | 1997 | 13 | 0.200 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2021 | 83 | 0.200 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2023 | 241 | 0.200 |
Why?
|
| Diacylglycerol Kinase | 1 | 2021 | 48 | 0.200 |
Why?
|
| Patient Selection | 5 | 2019 | 4215 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2021 | 203 | 0.190 |
Why?
|
| Cohort Studies | 20 | 2023 | 40561 | 0.190 |
Why?
|
| Endometrial Neoplasms | 2 | 2023 | 1353 | 0.190 |
Why?
|
| Mice, Mutant Strains | 5 | 2013 | 1866 | 0.190 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 694 | 0.190 |
Why?
|
| Recombination, Genetic | 5 | 2003 | 1586 | 0.190 |
Why?
|
| Tachykinins | 1 | 2021 | 78 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2009 | 1676 | 0.190 |
Why?
|
| Cell Survival | 8 | 2017 | 5882 | 0.190 |
Why?
|
| Nervous System Malformations | 1 | 2002 | 247 | 0.190 |
Why?
|
| rac GTP-Binding Proteins | 4 | 2003 | 164 | 0.190 |
Why?
|
| CD40 Ligand | 1 | 2002 | 526 | 0.190 |
Why?
|
| Muscles | 2 | 2020 | 1614 | 0.190 |
Why?
|
| Interleukins | 1 | 2005 | 791 | 0.190 |
Why?
|
| Cerebral Cortex | 6 | 2021 | 5708 | 0.190 |
Why?
|
| Reactive Oxygen Species | 3 | 2013 | 2077 | 0.190 |
Why?
|
| Cell Growth Processes | 3 | 2013 | 399 | 0.190 |
Why?
|
| Gene Duplication | 3 | 2008 | 329 | 0.180 |
Why?
|
| Point Mutation | 6 | 2006 | 1623 | 0.180 |
Why?
|
| Tamoxifen | 1 | 2005 | 981 | 0.180 |
Why?
|
| Alu Elements | 1 | 2000 | 119 | 0.180 |
Why?
|
| Lymphokines | 1 | 2003 | 949 | 0.180 |
Why?
|
| Transcription Factor AP-1 | 1 | 2001 | 317 | 0.180 |
Why?
|
| Transcription Initiation Site | 1 | 2020 | 196 | 0.180 |
Why?
|
| Tumor Escape | 1 | 2023 | 349 | 0.180 |
Why?
|
| Prospective Studies | 18 | 2023 | 53288 | 0.180 |
Why?
|
| Proteoglycans | 2 | 2018 | 835 | 0.180 |
Why?
|
| Young Adult | 20 | 2022 | 56430 | 0.180 |
Why?
|
| Profilins | 10 | 2001 | 66 | 0.180 |
Why?
|
| Lung | 10 | 2022 | 9856 | 0.180 |
Why?
|
| Genes | 5 | 1997 | 1893 | 0.180 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2023 | 1038 | 0.180 |
Why?
|
| Cyclin E | 1 | 2020 | 172 | 0.180 |
Why?
|
| Cell Nucleus | 5 | 2020 | 2969 | 0.180 |
Why?
|
| Astrocytes | 3 | 2021 | 1270 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 7 | 2021 | 4803 | 0.180 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2022 | 11524 | 0.180 |
Why?
|
| Gene Knockout Techniques | 2 | 2020 | 809 | 0.180 |
Why?
|
| Nodal Protein | 1 | 2019 | 37 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 1996 | 354 | 0.170 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2009 | 1363 | 0.170 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 1999 | 595 | 0.170 |
Why?
|
| Blotting, Western | 6 | 2013 | 5179 | 0.170 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2017 | 611 | 0.170 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1999 | 1801 | 0.170 |
Why?
|
| RNA, Messenger | 14 | 2016 | 13033 | 0.170 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2019 | 34 | 0.170 |
Why?
|
| Isoenzymes | 3 | 2004 | 1726 | 0.170 |
Why?
|
| Pedigree | 21 | 2009 | 4644 | 0.170 |
Why?
|
| Meningococcal Infections | 1 | 1999 | 77 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2023 | 9239 | 0.170 |
Why?
|
| Genetic Testing | 7 | 2018 | 3444 | 0.170 |
Why?
|
| Phenylenediamines | 1 | 2019 | 90 | 0.170 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2017 | 687 | 0.170 |
Why?
|
| Relapsing Fever | 1 | 1998 | 19 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2016 | 1285 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2014 | 2915 | 0.170 |
Why?
|
| Calcitriol | 2 | 1998 | 298 | 0.170 |
Why?
|
| Hair Color | 1 | 1999 | 136 | 0.170 |
Why?
|
| Albumins | 1 | 2021 | 569 | 0.160 |
Why?
|
| Polymorphism, Restriction Fragment Length | 7 | 1995 | 768 | 0.160 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1998 | 279 | 0.160 |
Why?
|
| Plasma | 3 | 2020 | 575 | 0.160 |
Why?
|
| Respiratory Function Tests | 4 | 2020 | 1616 | 0.160 |
Why?
|
| Neoplasm Transplantation | 2 | 2020 | 2085 | 0.160 |
Why?
|
| Heart Defects, Congenital | 3 | 2022 | 4584 | 0.160 |
Why?
|
| Cytoskeleton | 8 | 2000 | 1185 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2016 | 3508 | 0.160 |
Why?
|
| Oligonucleotide Probes | 4 | 2010 | 427 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 730 | 0.160 |
Why?
|
| Infant, Newborn | 9 | 2023 | 25625 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2021 | 4751 | 0.160 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2015 | 740 | 0.160 |
Why?
|
| Cell Cycle | 4 | 2014 | 2967 | 0.160 |
Why?
|
| MicroRNAs | 6 | 2021 | 3752 | 0.160 |
Why?
|
| Cytoplasm | 7 | 2008 | 1539 | 0.160 |
Why?
|
| Vimentin | 1 | 2018 | 261 | 0.160 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2018 | 134 | 0.160 |
Why?
|
| Rats | 18 | 2021 | 24260 | 0.160 |
Why?
|
| Leprosy, Lepromatous | 1 | 1997 | 23 | 0.150 |
Why?
|
| Receptors, Prostaglandin E, EP3 Subtype | 1 | 2017 | 23 | 0.150 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2018 | 105 | 0.150 |
Why?
|
| Genes, Neoplasm | 3 | 2021 | 376 | 0.150 |
Why?
|
| Disease Progression | 6 | 2019 | 13284 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2017 | 4034 | 0.150 |
Why?
|
| Lymphocyte Count | 1 | 2019 | 793 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2014 | 2916 | 0.150 |
Why?
|
| Carcinoma, Lobular | 1 | 2021 | 484 | 0.150 |
Why?
|
| Crohn Disease | 2 | 2009 | 2303 | 0.150 |
Why?
|
| Telencephalon | 1 | 2017 | 142 | 0.150 |
Why?
|
| Uterine Neoplasms | 3 | 2020 | 1513 | 0.150 |
Why?
|
| Myocardium | 3 | 2006 | 4776 | 0.150 |
Why?
|
| Cadherins | 1 | 2021 | 907 | 0.150 |
Why?
|
| Mice, SCID | 7 | 2017 | 2716 | 0.150 |
Why?
|
| Receptors, Cell Surface | 5 | 2004 | 2866 | 0.150 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 10180 | 0.140 |
Why?
|
| Neoplasms, Experimental | 3 | 2014 | 1276 | 0.140 |
Why?
|
| Acrylamides | 1 | 2018 | 255 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 250 | 0.140 |
Why?
|
| Centromere | 3 | 1995 | 220 | 0.140 |
Why?
|
| Superoxides | 4 | 2006 | 387 | 0.140 |
Why?
|
| Asthma | 9 | 2005 | 6011 | 0.140 |
Why?
|
| Receptors, Notch | 2 | 2013 | 739 | 0.140 |
Why?
|
| Myelin Sheath | 1 | 2020 | 652 | 0.140 |
Why?
|
| Malaria Vaccines | 1 | 1997 | 158 | 0.140 |
Why?
|
| MAP Kinase Kinase 1 | 3 | 2015 | 337 | 0.140 |
Why?
|
| Enzyme Activation | 9 | 2014 | 3701 | 0.140 |
Why?
|
| HEK293 Cells | 4 | 2019 | 4204 | 0.140 |
Why?
|
| Coronary Stenosis | 1 | 2022 | 834 | 0.140 |
Why?
|
| Pericytes | 1 | 2018 | 292 | 0.140 |
Why?
|
| Oligopeptides | 2 | 2018 | 1189 | 0.140 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2015 | 25 | 0.140 |
Why?
|
| RNA, Small Interfering | 7 | 2018 | 3505 | 0.140 |
Why?
|
| Pneumothorax | 1 | 2019 | 379 | 0.140 |
Why?
|
| Down-Regulation | 4 | 2022 | 3002 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1184 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 2012 | 0.130 |
Why?
|
| Collagen | 3 | 2004 | 2689 | 0.130 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 1998 | 1155 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2014 | 1213 | 0.130 |
Why?
|
| Neurofibromatosis 1 | 1 | 2001 | 569 | 0.130 |
Why?
|
| Bedding and Linens | 2 | 1996 | 41 | 0.130 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2015 | 2043 | 0.130 |
Why?
|
| Kinetics | 10 | 2008 | 6473 | 0.130 |
Why?
|
| Shock | 1 | 1998 | 318 | 0.130 |
Why?
|
| Smoking | 5 | 2022 | 8987 | 0.130 |
Why?
|
| Transfection | 13 | 2016 | 5892 | 0.130 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2014 | 31 | 0.130 |
Why?
|
| Monocytes | 3 | 2000 | 2596 | 0.130 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 1456 | 0.130 |
Why?
|
| Benzodiazepinones | 1 | 2014 | 51 | 0.130 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 733 | 0.130 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2014 | 137 | 0.130 |
Why?
|
| Genome-Wide Association Study | 5 | 2019 | 12261 | 0.120 |
Why?
|
| Neoadjuvant Therapy | 2 | 2022 | 2728 | 0.120 |
Why?
|
| Janus Kinase 1 | 2 | 2005 | 104 | 0.120 |
Why?
|
| Clinical Trials as Topic | 3 | 2023 | 7913 | 0.120 |
Why?
|
| Xenopus Proteins | 1 | 1997 | 433 | 0.120 |
Why?
|
| Haptoglobins | 1 | 1996 | 165 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2014 | 1504 | 0.120 |
Why?
|
| Phosphatidylinositols | 2 | 1995 | 291 | 0.120 |
Why?
|
| Sequence Homology, Nucleic Acid | 7 | 1999 | 1085 | 0.120 |
Why?
|
| Phospholipases A2 | 1 | 2014 | 203 | 0.120 |
Why?
|
| Bronchiolitis | 1 | 2000 | 458 | 0.120 |
Why?
|
| Treatment Outcome | 14 | 2022 | 63114 | 0.120 |
Why?
|
| PPAR gamma | 1 | 2017 | 493 | 0.120 |
Why?
|
| COS Cells | 4 | 2015 | 1161 | 0.120 |
Why?
|
| 6-Aminonicotinamide | 1 | 2013 | 8 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 1376 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3255 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2021 | 905 | 0.120 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2013 | 23 | 0.120 |
Why?
|
| Oncogenes | 2 | 2023 | 1265 | 0.120 |
Why?
|
| Enzyme Inhibitors | 7 | 2023 | 3798 | 0.120 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 1995 | 89 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2016 | 315 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2018 | 783 | 0.120 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 1199 | 0.120 |
Why?
|
| Aniline Compounds | 1 | 2018 | 986 | 0.120 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2013 | 23 | 0.120 |
Why?
|
| Restriction Mapping | 7 | 1995 | 878 | 0.120 |
Why?
|
| Fibrinogen | 2 | 2009 | 894 | 0.120 |
Why?
|
| Actinin | 3 | 1993 | 160 | 0.120 |
Why?
|
| Nerve Block | 1 | 2020 | 644 | 0.120 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2013 | 124 | 0.110 |
Why?
|
| Disease Transmission, Infectious | 1 | 2019 | 547 | 0.110 |
Why?
|
| Internationality | 1 | 2019 | 1003 | 0.110 |
Why?
|
| STAT1 Transcription Factor | 2 | 2005 | 320 | 0.110 |
Why?
|
| Pleural Neoplasms | 1 | 2018 | 607 | 0.110 |
Why?
|
| Antibodies, Protozoan | 1 | 1994 | 253 | 0.110 |
Why?
|
| Receptor, erbB-2 | 2 | 2014 | 2416 | 0.110 |
Why?
|
| cdc42 GTP-Binding Protein | 3 | 2000 | 194 | 0.110 |
Why?
|
| Receptors, Interferon | 2 | 2004 | 115 | 0.110 |
Why?
|
| Cytidine Deaminase | 1 | 2015 | 252 | 0.110 |
Why?
|
| Fever | 2 | 1993 | 1616 | 0.110 |
Why?
|
| Antimalarials | 3 | 1997 | 905 | 0.110 |
Why?
|
| Pseudopodia | 3 | 2006 | 172 | 0.110 |
Why?
|
| Resorcinols | 1 | 2013 | 38 | 0.110 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 1995 | 139 | 0.110 |
Why?
|
| Transcriptional Activation | 5 | 2010 | 1783 | 0.110 |
Why?
|
| Lung Diseases | 2 | 2022 | 1886 | 0.110 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 6773 | 0.110 |
Why?
|
| Antigens | 1 | 2018 | 1466 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2003 | 462 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2005 | 3690 | 0.110 |
Why?
|
| Protein-Arginine N-Methyltransferases | 2 | 2023 | 131 | 0.110 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 440 | 0.110 |
Why?
|
| Prostaglandins | 1 | 2014 | 405 | 0.110 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 2203 | 0.110 |
Why?
|
| Leydig Cell Tumor | 1 | 2012 | 25 | 0.110 |
Why?
|
| Animals, Newborn | 6 | 2011 | 2726 | 0.110 |
Why?
|
| Dendrites | 2 | 2008 | 485 | 0.110 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2006 | 3047 | 0.110 |
Why?
|
| Piperazines | 2 | 2021 | 2488 | 0.110 |
Why?
|
| Type C Phospholipases | 3 | 2005 | 292 | 0.110 |
Why?
|
| Color Perception | 1 | 1993 | 213 | 0.110 |
Why?
|
| Urea | 1 | 2014 | 450 | 0.110 |
Why?
|
| Hemangiosarcoma | 1 | 2014 | 239 | 0.110 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 7722 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 1333 | 0.100 |
Why?
|
| Carcinoma, Large Cell | 1 | 2012 | 113 | 0.100 |
Why?
|
| Prevalence | 6 | 2022 | 15226 | 0.100 |
Why?
|
| Enzyme Induction | 2 | 2005 | 475 | 0.100 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1993 | 207 | 0.100 |
Why?
|
| Carcinoma, Small Cell | 3 | 1997 | 420 | 0.100 |
Why?
|
| Kidney Diseases | 2 | 2002 | 2149 | 0.100 |
Why?
|
| Sunlight | 1 | 2013 | 325 | 0.100 |
Why?
|
| Immunity, Active | 1 | 1991 | 60 | 0.100 |
Why?
|
| Phosphoproteins | 3 | 2014 | 2440 | 0.100 |
Why?
|
| Mutation, Missense | 5 | 2009 | 2564 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2008 | 323 | 0.100 |
Why?
|
| Isoxazoles | 1 | 2013 | 216 | 0.100 |
Why?
|
| Pyridines | 2 | 2021 | 2825 | 0.100 |
Why?
|
| Codon | 2 | 2006 | 611 | 0.100 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2012 | 285 | 0.100 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 553 | 0.100 |
Why?
|
| Janus Kinase 2 | 2 | 2005 | 528 | 0.100 |
Why?
|
| Pan troglodytes | 2 | 2002 | 229 | 0.100 |
Why?
|
| Immunoglobulin M | 2 | 1994 | 1537 | 0.100 |
Why?
|
| Models, Biological | 8 | 2014 | 9583 | 0.100 |
Why?
|
| beta Catenin | 1 | 2016 | 1059 | 0.100 |
Why?
|
| Cell Differentiation | 9 | 2017 | 11483 | 0.100 |
Why?
|
| Argininosuccinate Synthase | 1 | 1991 | 15 | 0.100 |
Why?
|
| Binding Sites | 7 | 2001 | 6114 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 6 | 2018 | 2649 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2002 | 2839 | 0.100 |
Why?
|
| Hybrid Cells | 4 | 1993 | 441 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2021 | 4026 | 0.100 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2001 | 107 | 0.100 |
Why?
|
| DNA, Satellite | 1 | 1991 | 69 | 0.100 |
Why?
|
| Surface Plasmon Resonance | 1 | 2012 | 274 | 0.100 |
Why?
|
| Interleukin-1 | 7 | 1996 | 1263 | 0.100 |
Why?
|
| Microsatellite Repeats | 5 | 2003 | 802 | 0.100 |
Why?
|
| Microscopy, Electron | 2 | 2011 | 2645 | 0.090 |
Why?
|
| Penetrance | 3 | 2021 | 381 | 0.090 |
Why?
|
| Chloroquine | 4 | 2021 | 280 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 1972 | 0.090 |
Why?
|
| Blotting, Southern | 4 | 1998 | 803 | 0.090 |
Why?
|
| Spectrin | 2 | 1990 | 177 | 0.090 |
Why?
|
| Clone Cells | 3 | 2003 | 1692 | 0.090 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2010 | 76 | 0.090 |
Why?
|
| Imidazoles | 3 | 2017 | 1206 | 0.090 |
Why?
|
| Cosmids | 3 | 1995 | 107 | 0.090 |
Why?
|
| Caspase 3 | 4 | 2004 | 758 | 0.090 |
Why?
|
| Calcium | 9 | 2005 | 5756 | 0.090 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2012 | 186 | 0.090 |
Why?
|
| Deoxycytidine | 1 | 2014 | 826 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2017 | 795 | 0.090 |
Why?
|
| Lymphatic Metastasis | 4 | 2019 | 2924 | 0.090 |
Why?
|
| HLA Antigens | 5 | 1999 | 1381 | 0.090 |
Why?
|
| Levodopa | 1 | 1991 | 219 | 0.090 |
Why?
|
| src-Family Kinases | 1 | 2013 | 551 | 0.090 |
Why?
|
| Brain Diseases | 2 | 1997 | 1563 | 0.090 |
Why?
|
| Thiophenes | 1 | 2014 | 588 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2021 | 1905 | 0.090 |
Why?
|
| Retrospective Studies | 14 | 2023 | 77449 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2020 | 3537 | 0.090 |
Why?
|
| Genes, MHC Class II | 3 | 1997 | 457 | 0.090 |
Why?
|
| Alternative Splicing | 3 | 2000 | 1117 | 0.090 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 2 | 2006 | 42 | 0.090 |
Why?
|
| X Chromosome | 1 | 1993 | 814 | 0.090 |
Why?
|
| Membrane Glycoproteins | 5 | 2004 | 3768 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1991 | 380 | 0.090 |
Why?
|
| Ethylnitrosourea | 1 | 2009 | 51 | 0.090 |
Why?
|
| HeLa Cells | 5 | 2018 | 3128 | 0.090 |
Why?
|
| RNA Interference | 4 | 2017 | 2889 | 0.090 |
Why?
|
| Spasms, Infantile | 2 | 2020 | 305 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 3 | 2022 | 1677 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2009 | 99 | 0.090 |
Why?
|
| Apolipoproteins E | 2 | 2006 | 1438 | 0.080 |
Why?
|
| Anemia | 1 | 1999 | 1506 | 0.080 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1989 | 170 | 0.080 |
Why?
|
| Pyruvate Kinase | 1 | 2011 | 189 | 0.080 |
Why?
|
| Pyrazoles | 2 | 2022 | 1972 | 0.080 |
Why?
|
| Gene Expression | 9 | 2021 | 7799 | 0.080 |
Why?
|
| Facial Asymmetry | 1 | 1990 | 171 | 0.080 |
Why?
|
| Gene Fusion | 1 | 2012 | 371 | 0.080 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 39050 | 0.080 |
Why?
|
| Muscle, Smooth | 3 | 2017 | 934 | 0.080 |
Why?
|
| Hippocampus | 8 | 2014 | 3675 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1526 | 0.080 |
Why?
|
| Fetus | 4 | 2004 | 1880 | 0.080 |
Why?
|
| Tissue Distribution | 5 | 1999 | 2327 | 0.080 |
Why?
|
| Membrane Proteins | 9 | 2021 | 7880 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2000 | 534 | 0.080 |
Why?
|
| Gene Silencing | 2 | 2005 | 1538 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 2699 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1990 | 437 | 0.080 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3647 | 0.080 |
Why?
|
| Erythrocytes | 5 | 1999 | 2455 | 0.080 |
Why?
|
| Myocytes, Cardiac | 2 | 2014 | 1637 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 4 | 2015 | 4462 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 1992 | 895 | 0.080 |
Why?
|
| Organ Specificity | 3 | 1998 | 2008 | 0.080 |
Why?
|
| Endotoxins | 1 | 2010 | 527 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 6 | 2005 | 9274 | 0.080 |
Why?
|
| Gold | 1 | 2012 | 484 | 0.080 |
Why?
|
| Genes, Dominant | 4 | 2003 | 880 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 625 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2005 | 3617 | 0.080 |
Why?
|
| Genome | 2 | 2007 | 1808 | 0.080 |
Why?
|
| Dimerization | 2 | 2000 | 893 | 0.080 |
Why?
|
| Hepatocytes | 2 | 2012 | 1211 | 0.080 |
Why?
|
| Ribosomal Protein S6 | 2 | 2004 | 70 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1998 | 1832 | 0.080 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2008 | 133 | 0.080 |
Why?
|
| Women's Health | 2 | 2009 | 2034 | 0.080 |
Why?
|
| HLA-DR Antigens | 3 | 2002 | 645 | 0.080 |
Why?
|
| Adipocytes | 1 | 2014 | 1184 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 1998 | 3036 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 3870 | 0.080 |
Why?
|
| Epoxy Compounds | 2 | 2005 | 136 | 0.080 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2017 | 890 | 0.080 |
Why?
|
| Reproducibility of Results | 7 | 2020 | 19905 | 0.080 |
Why?
|
| Skin Neoplasms | 3 | 2019 | 5686 | 0.080 |
Why?
|
| Receptors, Glutamate | 1 | 2008 | 232 | 0.070 |
Why?
|
| Quinolines | 2 | 2009 | 732 | 0.070 |
Why?
|
| Genes, ras | 3 | 2015 | 690 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 822 | 0.070 |
Why?
|
| Podocytes | 1 | 2011 | 396 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 6487 | 0.070 |
Why?
|
| United States | 12 | 2022 | 69872 | 0.070 |
Why?
|
| Germ Cells | 2 | 2022 | 631 | 0.070 |
Why?
|
| Logistic Models | 2 | 2019 | 13408 | 0.070 |
Why?
|
| Platelet Activation | 2 | 1996 | 673 | 0.070 |
Why?
|
| Behavior, Animal | 2 | 2012 | 1881 | 0.070 |
Why?
|
| Coma | 3 | 1997 | 475 | 0.070 |
Why?
|
| Nanostructures | 1 | 2012 | 551 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 2126 | 0.070 |
Why?
|
| DNA Methylation | 4 | 2018 | 4286 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2002 | 3712 | 0.070 |
Why?
|
| Pediatrics | 1 | 2022 | 3475 | 0.070 |
Why?
|
| Granulocytes | 1 | 1988 | 548 | 0.070 |
Why?
|
| Human Genome Project | 1 | 2007 | 193 | 0.070 |
Why?
|
| Chromosomes, Human | 2 | 2014 | 457 | 0.070 |
Why?
|
| Skin | 2 | 2016 | 4364 | 0.070 |
Why?
|
| Mice, Inbred CBA | 1 | 2007 | 448 | 0.070 |
Why?
|
| Muscle Proteins | 2 | 2011 | 1159 | 0.070 |
Why?
|
| Chromosome Breakage | 1 | 2007 | 173 | 0.070 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2007 | 168 | 0.070 |
Why?
|
| Cell Membrane | 4 | 2002 | 3748 | 0.070 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 3703 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1987 | 374 | 0.070 |
Why?
|
| Hepatitis B | 3 | 1998 | 695 | 0.070 |
Why?
|
| Kidney Tubules | 1 | 2008 | 488 | 0.070 |
Why?
|
| Pericardial Effusion | 1 | 2008 | 247 | 0.070 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 2 | 1997 | 89 | 0.070 |
Why?
|
| Risk Factors | 10 | 2019 | 72290 | 0.070 |
Why?
|
| Cough | 2 | 2019 | 555 | 0.070 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2007 | 293 | 0.070 |
Why?
|
| Testicular Neoplasms | 1 | 2012 | 804 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2021 | 643 | 0.070 |
Why?
|
| Estrenes | 1 | 2005 | 23 | 0.070 |
Why?
|
| Algorithms | 3 | 2023 | 13881 | 0.070 |
Why?
|
| Focal Adhesions | 1 | 2006 | 121 | 0.070 |
Why?
|
| Selection, Genetic | 3 | 2001 | 914 | 0.070 |
Why?
|
| HLA-B35 Antigen | 2 | 1998 | 8 | 0.070 |
Why?
|
| Water | 1 | 2012 | 1395 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2017 | 1878 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2008 | 689 | 0.070 |
Why?
|
| Proto-Oncogenes | 2 | 2018 | 321 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 453 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2019 | 20129 | 0.060 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2018 | 449 | 0.060 |
Why?
|
| Leiomyoma | 2 | 2013 | 730 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2005 | 158 | 0.060 |
Why?
|
| Biopsy | 1 | 2017 | 6756 | 0.060 |
Why?
|
| Allyl Compounds | 1 | 2004 | 23 | 0.060 |
Why?
|
| Chromones | 1 | 2005 | 154 | 0.060 |
Why?
|
| beta-Defensins | 1 | 2005 | 57 | 0.060 |
Why?
|
| Jews | 3 | 1992 | 385 | 0.060 |
Why?
|
| Interleukin-6 | 4 | 2021 | 3200 | 0.060 |
Why?
|
| Antigens, Protozoan | 3 | 2001 | 322 | 0.060 |
Why?
|
| Electron Transport | 1 | 2005 | 211 | 0.060 |
Why?
|
| Hominidae | 2 | 1995 | 74 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2008 | 686 | 0.060 |
Why?
|
| Myosin Light Chains | 1 | 2004 | 121 | 0.060 |
Why?
|
| Pyrrolidinones | 1 | 2005 | 117 | 0.060 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2003 | 212 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2002 | 2256 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 1655 | 0.060 |
Why?
|
| Crosses, Genetic | 2 | 2003 | 791 | 0.060 |
Why?
|
| Family | 2 | 2007 | 3147 | 0.060 |
Why?
|
| Forced Expiratory Volume | 6 | 2006 | 1743 | 0.060 |
Why?
|
| Antibodies | 4 | 2001 | 2460 | 0.060 |
Why?
|
| Glioma, Subependymal | 1 | 2004 | 3 | 0.060 |
Why?
|
| Species Specificity | 3 | 1999 | 2478 | 0.060 |
Why?
|
| Alcohols | 1 | 2004 | 92 | 0.060 |
Why?
|
| Cardiac Myosins | 1 | 2004 | 117 | 0.060 |
Why?
|
| Stroke | 2 | 2022 | 9981 | 0.060 |
Why?
|
| Glycogen | 1 | 2004 | 260 | 0.060 |
Why?
|
| Fibronectins | 2 | 2005 | 726 | 0.060 |
Why?
|
| Gene Components | 1 | 2003 | 29 | 0.060 |
Why?
|
| Receptors, Prostaglandin | 1 | 2004 | 57 | 0.060 |
Why?
|
| Acidosis, Lactic | 2 | 1997 | 142 | 0.060 |
Why?
|
| Disease Susceptibility | 3 | 2001 | 1782 | 0.060 |
Why?
|
| Brain Chemistry | 2 | 1998 | 981 | 0.060 |
Why?
|
| Time Factors | 8 | 2012 | 40075 | 0.060 |
Why?
|
| Nucleic Acid Denaturation | 2 | 2001 | 111 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 20822 | 0.060 |
Why?
|
| Diabetic Nephropathies | 1 | 2011 | 984 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2007 | 572 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2007 | 435 | 0.060 |
Why?
|
| Genetics, Population | 2 | 2004 | 934 | 0.060 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2023 | 27 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2007 | 535 | 0.060 |
Why?
|
| Phosphatidylinositol Phosphates | 3 | 2000 | 209 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2008 | 3386 | 0.060 |
Why?
|
| Serum | 1 | 2005 | 214 | 0.060 |
Why?
|
| Protein Binding | 7 | 2012 | 9386 | 0.060 |
Why?
|
| Endopeptidases | 1 | 1987 | 772 | 0.060 |
Why?
|
| Odds Ratio | 5 | 2001 | 9849 | 0.060 |
Why?
|
| Feedback | 2 | 2005 | 795 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2018 | 3086 | 0.060 |
Why?
|
| Physicians | 1 | 2022 | 4567 | 0.060 |
Why?
|
| Ketones | 1 | 2004 | 188 | 0.060 |
Why?
|
| Cell Adhesion | 4 | 2004 | 3144 | 0.060 |
Why?
|
| Amyloidosis | 3 | 1999 | 795 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2009 | 1063 | 0.060 |
Why?
|
| Karyotyping | 3 | 1990 | 1243 | 0.060 |
Why?
|
| Ribonucleases | 3 | 1988 | 287 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2004 | 188 | 0.060 |
Why?
|
| Puberty | 1 | 2006 | 490 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2003 | 104 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2005 | 2187 | 0.060 |
Why?
|
| Tumor Burden | 2 | 2022 | 1915 | 0.060 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 2005 | 191 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 329 | 0.060 |
Why?
|
| Ascitic Fluid | 1 | 2003 | 192 | 0.060 |
Why?
|
| Electroencephalography | 4 | 2021 | 6150 | 0.050 |
Why?
|
| Africa | 3 | 2001 | 673 | 0.050 |
Why?
|
| Etoposide | 3 | 1997 | 641 | 0.050 |
Why?
|
| Protein Subunits | 2 | 2008 | 959 | 0.050 |
Why?
|
| Carrier State | 2 | 1998 | 518 | 0.050 |
Why?
|
| Laminin | 1 | 2004 | 419 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2529 | 0.050 |
Why?
|
| Hypoglycemia | 3 | 1997 | 861 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2003 | 202 | 0.050 |
Why?
|
| S Phase | 1 | 2004 | 423 | 0.050 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2002 | 92 | 0.050 |
Why?
|
| Family Health | 3 | 2009 | 1282 | 0.050 |
Why?
|
| Metalloendopeptidases | 1 | 2004 | 396 | 0.050 |
Why?
|
| Immunoglobulin G | 2 | 2001 | 4560 | 0.050 |
Why?
|
| Toll-Like Receptors | 2 | 2002 | 592 | 0.050 |
Why?
|
| Mitochondria | 4 | 2013 | 3520 | 0.050 |
Why?
|
| Fos-Related Antigen-2 | 1 | 2001 | 15 | 0.050 |
Why?
|
| Genetic Loci | 2 | 2009 | 2575 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 489 | 0.050 |
Why?
|
| Lysosomes | 2 | 2021 | 893 | 0.050 |
Why?
|
| Prostate | 1 | 2010 | 1774 | 0.050 |
Why?
|
| Choline | 1 | 2004 | 493 | 0.050 |
Why?
|
| Rats, Nude | 1 | 2021 | 105 | 0.050 |
Why?
|
| Lymphangiomyoma | 1 | 2001 | 10 | 0.050 |
Why?
|
| Axons | 2 | 2008 | 1684 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2023 | 378 | 0.050 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2004 | 139 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2009 | 891 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 772 | 0.050 |
Why?
|
| Morpholines | 1 | 2005 | 571 | 0.050 |
Why?
|
| Dyspnea | 2 | 2019 | 1303 | 0.050 |
Why?
|
| Bradycardia | 1 | 2023 | 307 | 0.050 |
Why?
|
| Protein Conformation | 5 | 2014 | 4011 | 0.050 |
Why?
|
| Hepatitis B virus | 2 | 1995 | 513 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2000 | 743 | 0.050 |
Why?
|
| Biopsy, Needle | 2 | 2018 | 1641 | 0.050 |
Why?
|
| Depsipeptides | 1 | 2002 | 94 | 0.050 |
Why?
|
| Engineering | 1 | 2021 | 58 | 0.050 |
Why?
|
| Angiolipoma | 1 | 2021 | 13 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2017 | 2504 | 0.050 |
Why?
|
| Recombinant Proteins | 8 | 2008 | 6622 | 0.050 |
Why?
|
| Genealogy and Heraldry | 1 | 2021 | 28 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 1998 | 190 | 0.050 |
Why?
|
| Cisplatin | 2 | 2023 | 1662 | 0.050 |
Why?
|
| Neurotoxins | 2 | 2004 | 237 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2002 | 528 | 0.050 |
Why?
|
| Phosphatidic Acids | 1 | 2021 | 49 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 4 | 2015 | 2088 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 2282 | 0.050 |
Why?
|
| Heart Ventricles | 2 | 2022 | 3821 | 0.050 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2002 | 178 | 0.050 |
Why?
|
| Cytochromes c | 1 | 2021 | 180 | 0.050 |
Why?
|
| Calcium Channels | 3 | 2004 | 622 | 0.050 |
Why?
|
| Peritonitis | 1 | 2003 | 365 | 0.050 |
Why?
|
| Computational Biology | 3 | 2021 | 3521 | 0.050 |
Why?
|
| Histocompatibility Testing | 2 | 1994 | 741 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 2421 | 0.050 |
Why?
|
| Body Weight | 1 | 2012 | 4669 | 0.050 |
Why?
|
| Neural Crest | 2 | 2017 | 275 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2001 | 286 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2008 | 1351 | 0.050 |
Why?
|
| Age Factors | 4 | 2008 | 18370 | 0.050 |
Why?
|
| Temperature | 3 | 2000 | 2206 | 0.050 |
Why?
|
| Chromosome Banding | 2 | 1991 | 278 | 0.050 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2001 | 91 | 0.050 |
Why?
|
| Chromosomes, Human, X | 1 | 2002 | 296 | 0.050 |
Why?
|
| Psoriasis | 1 | 2009 | 898 | 0.050 |
Why?
|
| Mental Disorders | 2 | 2019 | 6600 | 0.050 |
Why?
|
| Neutrophil Infiltration | 1 | 2003 | 390 | 0.050 |
Why?
|
| Regression Analysis | 4 | 1999 | 6459 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 6538 | 0.050 |
Why?
|
| Malawi | 1 | 2001 | 282 | 0.050 |
Why?
|
| DNA Mismatch Repair | 1 | 2023 | 426 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2000 | 252 | 0.050 |
Why?
|
| Leg Bones | 1 | 2000 | 19 | 0.050 |
Why?
|
| Transcription Factor RelA | 1 | 2001 | 275 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 1224 | 0.050 |
Why?
|
| Wound Healing | 2 | 2006 | 2785 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2016 | 3309 | 0.050 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2001 | 165 | 0.050 |
Why?
|
| Cholesterol, LDL | 2 | 2008 | 2356 | 0.050 |
Why?
|
| Microsatellite Instability | 1 | 2023 | 684 | 0.050 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2012 | 2408 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 675 | 0.050 |
Why?
|
| Models, Immunological | 1 | 2002 | 527 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2003 | 739 | 0.050 |
Why?
|
| Schizosaccharomyces | 1 | 2002 | 237 | 0.050 |
Why?
|
| Cholesterol | 1 | 2009 | 2917 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2012 | 2214 | 0.050 |
Why?
|
| Kenya | 2 | 2000 | 685 | 0.050 |
Why?
|
| Magnesium | 1 | 2023 | 813 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2002 | 360 | 0.040 |
Why?
|
| Leishmaniasis, Mucocutaneous | 1 | 1999 | 12 | 0.040 |
Why?
|
| Collectins | 1 | 1999 | 18 | 0.040 |
Why?
|
| Norway | 1 | 2021 | 448 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 14722 | 0.040 |
Why?
|
| HLA-DR3 Antigen | 1 | 1999 | 34 | 0.040 |
Why?
|
| Tropical Climate | 2 | 1997 | 37 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2000 | 188 | 0.040 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 1999 | 32 | 0.040 |
Why?
|
| Consensus | 2 | 2020 | 2959 | 0.040 |
Why?
|
| Heteroduplex Analysis | 1 | 1999 | 8 | 0.040 |
Why?
|
| Sex Factors | 4 | 2015 | 10397 | 0.040 |
Why?
|
| Host Cell Factor C1 | 1 | 1999 | 31 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2004 | 638 | 0.040 |
Why?
|
| Keratins | 1 | 2021 | 515 | 0.040 |
Why?
|
| Phthiraptera | 1 | 1998 | 2 | 0.040 |
Why?
|
| Lymphotoxin-alpha | 1 | 1999 | 96 | 0.040 |
Why?
|
| Cell Communication | 1 | 2006 | 1621 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2003 | 798 | 0.040 |
Why?
|
| Observer Variation | 2 | 2020 | 2593 | 0.040 |
Why?
|
| Mannans | 1 | 1999 | 63 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2004 | 748 | 0.040 |
Why?
|
| Leprosy | 1 | 1999 | 124 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2002 | 895 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2017 | 2715 | 0.040 |
Why?
|
| Disease Vectors | 1 | 1998 | 60 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2001 | 575 | 0.040 |
Why?
|
| Protein Methyltransferases | 1 | 2018 | 55 | 0.040 |
Why?
|
| Paclitaxel | 2 | 1997 | 1708 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2004 | 1959 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2000 | 276 | 0.040 |
Why?
|
| Gene Rearrangement | 2 | 2015 | 1179 | 0.040 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 1998 | 47 | 0.040 |
Why?
|
| Ifosfamide | 2 | 1997 | 228 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 1998 | 98 | 0.040 |
Why?
|
| Borrelia | 1 | 1998 | 67 | 0.040 |
Why?
|
| Learning | 1 | 2008 | 1713 | 0.040 |
Why?
|
| Glioma | 2 | 2007 | 3401 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2001 | 675 | 0.040 |
Why?
|
| Ischemia | 2 | 2008 | 1907 | 0.040 |
Why?
|
| Models, Genetic | 4 | 2013 | 3494 | 0.040 |
Why?
|
| Karnofsky Performance Status | 1 | 1998 | 173 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2018 | 58 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2021 | 509 | 0.040 |
Why?
|
| Calcium Channels, L-Type | 1 | 1999 | 240 | 0.040 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2017 | 23 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2023 | 8324 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 2 | 1999 | 936 | 0.040 |
Why?
|
| Syndrome | 2 | 1998 | 3251 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 1995 | 95 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 1998 | 365 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 964 | 0.040 |
Why?
|
| ral Guanine Nucleotide Exchange Factor | 1 | 1997 | 4 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 655 | 0.040 |
Why?
|
| Leprosy, Tuberculoid | 1 | 1997 | 15 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2001 | 1147 | 0.040 |
Why?
|
| Organelles | 1 | 2000 | 264 | 0.040 |
Why?
|
| HLA-DR2 Antigen | 1 | 1997 | 48 | 0.040 |
Why?
|
| Morphogenesis | 2 | 2000 | 752 | 0.040 |
Why?
|
| Receptors, Steroid | 1 | 1998 | 155 | 0.040 |
Why?
|
| Insulin Resistance | 2 | 2009 | 3864 | 0.040 |
Why?
|
| Bradykinin | 1 | 1998 | 214 | 0.040 |
Why?
|
| rap GTP-Binding Proteins | 1 | 1997 | 28 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2009 | 2899 | 0.040 |
Why?
|
| Kainic Acid | 1 | 1997 | 199 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2004 | 810 | 0.040 |
Why?
|
| Receptors, Complement | 1 | 1998 | 264 | 0.040 |
Why?
|
| Heart | 2 | 2011 | 4467 | 0.040 |
Why?
|
| Parasitic Diseases | 1 | 1997 | 75 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2014 | 658 | 0.040 |
Why?
|
| Epigenomics | 1 | 2023 | 903 | 0.040 |
Why?
|
| Phospholipids | 1 | 2021 | 784 | 0.040 |
Why?
|
| Lipids | 1 | 2008 | 3305 | 0.040 |
Why?
|
| Vietnam | 1 | 1998 | 408 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 706 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2013 | 1086 | 0.040 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1998 | 262 | 0.040 |
Why?
|
| Injections, Intramuscular | 2 | 1996 | 552 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2018 | 1142 | 0.040 |
Why?
|
| Benchmarking | 1 | 2023 | 1042 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2013 | 1157 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2017 | 387 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 2 | 2014 | 611 | 0.040 |
Why?
|
| Lidocaine | 1 | 2020 | 544 | 0.040 |
Why?
|
| Genes, p53 | 2 | 2011 | 755 | 0.040 |
Why?
|
| Catheters | 1 | 2020 | 425 | 0.040 |
Why?
|
| Estrogens | 1 | 2004 | 1566 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2020 | 517 | 0.040 |
Why?
|
| Thalassemia | 1 | 1997 | 273 | 0.040 |
Why?
|
| Endothelial Cells | 3 | 2022 | 3479 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 1999 | 546 | 0.040 |
Why?
|
| Cognition | 2 | 2011 | 6770 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2009 | 2020 | 0.040 |
Why?
|
| Crossing Over, Genetic | 2 | 1993 | 95 | 0.040 |
Why?
|
| Tissue Adhesions | 1 | 1998 | 235 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2017 | 408 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2000 | 1547 | 0.040 |
Why?
|
| Cytochalasin D | 3 | 2002 | 92 | 0.040 |
Why?
|
| Cysts | 1 | 2002 | 678 | 0.040 |
Why?
|
| RNA, Ribosomal | 1 | 2017 | 246 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2000 | 1099 | 0.040 |
Why?
|
| Listeria monocytogenes | 1 | 1998 | 250 | 0.040 |
Why?
|
| Molecular Weight | 2 | 1997 | 2255 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2017 | 408 | 0.030 |
Why?
|
| Permethrin | 1 | 1996 | 16 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 2007 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 386 | 0.030 |
Why?
|
| Tongue | 1 | 1999 | 406 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 2000 | 1246 | 0.030 |
Why?
|
| Dithiothreitol | 1 | 1976 | 101 | 0.030 |
Why?
|
| Toxins, Biological | 1 | 1996 | 66 | 0.030 |
Why?
|
| Hyperplasia | 2 | 2014 | 1185 | 0.030 |
Why?
|
| Paresis | 1 | 1997 | 179 | 0.030 |
Why?
|
| Lipid Metabolism | 2 | 2008 | 1889 | 0.030 |
Why?
|
| Inflammation | 3 | 2009 | 10638 | 0.030 |
Why?
|
| Buthionine Sulfoximine | 1 | 2015 | 18 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2021 | 5974 | 0.030 |
Why?
|
| Pyrethrins | 1 | 1996 | 47 | 0.030 |
Why?
|
| Rabbits | 4 | 1998 | 4894 | 0.030 |
Why?
|
| DNA Repair | 2 | 2016 | 2046 | 0.030 |
Why?
|
| Osteoclasts | 1 | 2000 | 729 | 0.030 |
Why?
|
| Cell Death | 3 | 2013 | 1706 | 0.030 |
Why?
|
| Carboplatin | 2 | 1997 | 801 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 4456 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 2148 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 764 | 0.030 |
Why?
|
| Hepatitis B Antigens | 1 | 1995 | 40 | 0.030 |
Why?
|
| Organoids | 1 | 2021 | 701 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2000 | 1730 | 0.030 |
Why?
|
| Carbachol | 1 | 1976 | 226 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 328 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3920 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 15540 | 0.030 |
Why?
|
| Nervous System | 1 | 1999 | 554 | 0.030 |
Why?
|
| Neurites | 1 | 1997 | 388 | 0.030 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1995 | 82 | 0.030 |
Why?
|
| Unconsciousness | 1 | 1997 | 263 | 0.030 |
Why?
|
| Spirometry | 3 | 2003 | 864 | 0.030 |
Why?
|
| Parasitemia | 1 | 1996 | 174 | 0.030 |
Why?
|
| Antigens, Neoplasm | 3 | 2016 | 1988 | 0.030 |
Why?
|
| Ataxia | 1 | 1997 | 304 | 0.030 |
Why?
|
| Mosquito Control | 1 | 1996 | 104 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 563 | 0.030 |
Why?
|
| Metabolomics | 2 | 2014 | 1484 | 0.030 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2014 | 23 | 0.030 |
Why?
|
| RNA Splicing | 2 | 1991 | 907 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1850 | 0.030 |
Why?
|
| DNA Damage | 2 | 2016 | 2432 | 0.030 |
Why?
|
| Xeroderma Pigmentosum | 1 | 1994 | 31 | 0.030 |
Why?
|
| Genes, erbB-2 | 1 | 2015 | 162 | 0.030 |
Why?
|
| Teichoic Acids | 1 | 1994 | 66 | 0.030 |
Why?
|
| Hepatitis B Antibodies | 1 | 1995 | 159 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2019 | 695 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2014 | 98 | 0.030 |
Why?
|
| Hypothyroidism | 1 | 2019 | 658 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 677 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2020 | 859 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 2635 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2011 | 11725 | 0.030 |
Why?
|
| Genes, erbB-1 | 1 | 2015 | 161 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2017 | 767 | 0.030 |
Why?
|
| Transduction, Genetic | 2 | 2009 | 913 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2015 | 298 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2014 | 425 | 0.030 |
Why?
|
| Histidine | 1 | 1995 | 313 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 12959 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2018 | 670 | 0.030 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 1994 | 40 | 0.030 |
Why?
|
| Poland | 1 | 2014 | 184 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 1998 | 1150 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 713 | 0.030 |
Why?
|
| Insecticides | 1 | 1996 | 195 | 0.030 |
Why?
|
| ABO Blood-Group System | 2 | 1993 | 367 | 0.030 |
Why?
|
| Subcellular Fractions | 2 | 2008 | 547 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 1106 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 2 | 2011 | 1144 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 1998 | 1341 | 0.030 |
Why?
|
| Mice, Inbred A | 1 | 2013 | 248 | 0.030 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2013 | 52 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2018 | 541 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1995 | 305 | 0.030 |
Why?
|
| Ion Channels | 1 | 1999 | 1056 | 0.030 |
Why?
|
| Nipples | 1 | 2015 | 219 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 1999 | 1284 | 0.030 |
Why?
|
| Proteomics | 1 | 2007 | 3638 | 0.030 |
Why?
|
| Acetylcholine | 1 | 1976 | 621 | 0.030 |
Why?
|
| Thymine Nucleotides | 1 | 2013 | 63 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 1998 | 1097 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1970 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1994 | 326 | 0.030 |
Why?
|
| Hypersensitivity | 1 | 2002 | 1102 | 0.030 |
Why?
|
| Age Distribution | 2 | 2015 | 2902 | 0.030 |
Why?
|
| Amino Acids | 2 | 2014 | 1736 | 0.030 |
Why?
|
| Teratogens | 1 | 2013 | 112 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2006 | 2788 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 3 | 2002 | 964 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2014 | 367 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 1999 | 1364 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2000 | 1678 | 0.030 |
Why?
|
| Pregnancy | 5 | 2012 | 29144 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2013 | 224 | 0.030 |
Why?
|
| Histology | 1 | 2012 | 16 | 0.030 |
Why?
|
| Chickens | 2 | 1996 | 865 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2014 | 6895 | 0.030 |
Why?
|
| Leukocytes | 2 | 1999 | 2043 | 0.030 |
Why?
|
| Breath Tests | 1 | 2014 | 280 | 0.030 |
Why?
|
| Teaching | 1 | 2020 | 1174 | 0.030 |
Why?
|
| International Agencies | 1 | 2013 | 240 | 0.030 |
Why?
|
| Rosette Formation | 1 | 1992 | 153 | 0.030 |
Why?
|
| Synapsins | 1 | 2012 | 43 | 0.030 |
Why?
|
| Vocalization, Animal | 1 | 2012 | 87 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2008 | 644 | 0.030 |
Why?
|
| Nitric Oxide | 2 | 1998 | 2132 | 0.030 |
Why?
|
| Melioidosis | 1 | 1992 | 8 | 0.030 |
Why?
|
| Synapses | 1 | 2002 | 1728 | 0.030 |
Why?
|
| Sulfonamides | 2 | 2017 | 1938 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2019 | 838 | 0.030 |
Why?
|
| Porphyrins | 1 | 2014 | 348 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 8301 | 0.030 |
Why?
|
| Simian virus 40 | 1 | 1993 | 295 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 941 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 1836 | 0.030 |
Why?
|
| Liver | 3 | 2012 | 7474 | 0.030 |
Why?
|
| Hemostasis | 1 | 1995 | 458 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 503 | 0.030 |
Why?
|
| Phthalazines | 1 | 2014 | 363 | 0.030 |
Why?
|
| Age of Onset | 3 | 2005 | 3271 | 0.030 |
Why?
|
| Cell Line, Transformed | 2 | 1995 | 898 | 0.030 |
Why?
|
| Pyramidal Cells | 2 | 2005 | 363 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 1998 | 827 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 1997 | 1169 | 0.030 |
Why?
|
| Survival | 1 | 2012 | 163 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 15076 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2002 | 1583 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 12354 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 1996 | 518 | 0.030 |
Why?
|
| Immune Sera | 1 | 1992 | 641 | 0.030 |
Why?
|
| Adsorption | 1 | 2012 | 201 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1999 | 1504 | 0.030 |
Why?
|
| Reference Values | 1 | 1999 | 4982 | 0.030 |
Why?
|
| DNA, Recombinant | 2 | 1992 | 476 | 0.030 |
Why?
|
| Fanconi Anemia | 1 | 1994 | 319 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 1999 | 1257 | 0.030 |
Why?
|
| Glomerular Basement Membrane | 1 | 2011 | 33 | 0.030 |
Why?
|
| Lod Score | 2 | 2002 | 614 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 2703 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 10943 | 0.020 |
Why?
|
| Intelligence | 2 | 2007 | 920 | 0.020 |
Why?
|
| Glomerular Mesangium | 1 | 2011 | 108 | 0.020 |
Why?
|
| Virus Diseases | 1 | 1997 | 711 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 1993 | 565 | 0.020 |
Why?
|
| Solutions | 1 | 2012 | 426 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2015 | 1266 | 0.020 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 1992 | 81 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 1992 | 258 | 0.020 |
Why?
|
| HLA-B27 Antigen | 1 | 1991 | 76 | 0.020 |
Why?
|
| Liposomes | 1 | 1994 | 759 | 0.020 |
Why?
|
| Aerobiosis | 1 | 2011 | 106 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2017 | 1172 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 2 | 2002 | 185 | 0.020 |
Why?
|
| Incidence | 2 | 2022 | 20947 | 0.020 |
Why?
|
| Rural Population | 1 | 2001 | 2210 | 0.020 |
Why?
|
| Lipoxins | 1 | 2014 | 412 | 0.020 |
Why?
|
| Polydeoxyribonucleotides | 1 | 1992 | 127 | 0.020 |
Why?
|
| Reflex | 1 | 2012 | 365 | 0.020 |
Why?
|
| Maze Learning | 1 | 2012 | 478 | 0.020 |
Why?
|
| Gene Conversion | 1 | 1991 | 71 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2015 | 594 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2006 | 1827 | 0.020 |
Why?
|
| Remission Induction | 2 | 2012 | 2386 | 0.020 |
Why?
|
| Expert Testimony | 1 | 2013 | 356 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2001 | 1723 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1998 | 1821 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2014 | 6365 | 0.020 |
Why?
|
| Goals | 1 | 2016 | 706 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 269 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2022 | 35421 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2297 | 0.020 |
Why?
|
| Parents | 1 | 2004 | 3407 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2012 | 336 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 1736 | 0.020 |
Why?
|
| Acute-Phase Reaction | 2 | 2006 | 91 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1992 | 460 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2183 | 0.020 |
Why?
|
| Chi-Square Distribution | 3 | 2004 | 3508 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2012 | 298 | 0.020 |
Why?
|
| Actin Depolymerizing Factors | 3 | 1997 | 43 | 0.020 |
Why?
|
| Hernia, Inguinal | 1 | 1992 | 210 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1783 | 0.020 |
Why?
|
| Dystonia | 1 | 1993 | 363 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 2505 | 0.020 |
Why?
|
| Hydroxychloroquine | 1 | 2013 | 412 | 0.020 |
Why?
|
| 3T3 Cells | 3 | 1998 | 1101 | 0.020 |
Why?
|
| Fluorescence | 1 | 1992 | 751 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2010 | 130 | 0.020 |
Why?
|
| Arginine | 2 | 2008 | 944 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1990 | 299 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2011 | 212 | 0.020 |
Why?
|
| Genes, myc | 1 | 2011 | 399 | 0.020 |
Why?
|
| Melanocortins | 1 | 2009 | 11 | 0.020 |
Why?
|
| Patient Admission | 1 | 1997 | 1380 | 0.020 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2009 | 33 | 0.020 |
Why?
|
| HLA-B Antigens | 1 | 1991 | 353 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 2291 | 0.020 |
Why?
|
| Telomerase | 1 | 2014 | 730 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 8642 | 0.020 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 2 | 1999 | 112 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2009 | 73 | 0.020 |
Why?
|
| Insulin | 3 | 2011 | 6580 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2009 | 112 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 817 | 0.020 |
Why?
|
| Behavior | 1 | 2012 | 561 | 0.020 |
Why?
|
| Alcoholism | 1 | 2019 | 1906 | 0.020 |
Why?
|
| Cationic Amino Acid Transporter 1 | 1 | 2008 | 5 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1997 | 1401 | 0.020 |
Why?
|
| Critical Care | 1 | 2022 | 2647 | 0.020 |
Why?
|
| Surface Properties | 1 | 2012 | 1184 | 0.020 |
Why?
|
| Research | 1 | 1997 | 1999 | 0.020 |
Why?
|
| Dopamine beta-Hydroxylase | 3 | 1995 | 75 | 0.020 |
Why?
|
| Hyperphagia | 1 | 2009 | 136 | 0.020 |
Why?
|
| Plasmodium | 1 | 1991 | 250 | 0.020 |
Why?
|
| Curriculum | 1 | 2022 | 3605 | 0.020 |
Why?
|
| Membrane Potentials | 2 | 2004 | 1137 | 0.020 |
Why?
|
| Threonine | 1 | 2009 | 279 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 1999 | 2725 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 1989 | 281 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2009 | 163 | 0.020 |
Why?
|
| Radiography | 2 | 2014 | 7023 | 0.020 |
Why?
|
| China | 1 | 2014 | 2248 | 0.020 |
Why?
|
| Materials Testing | 1 | 2012 | 867 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 2008 | 109 | 0.020 |
Why?
|
| Quinazolinones | 1 | 2010 | 221 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2013 | 602 | 0.020 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2009 | 143 | 0.020 |
Why?
|
| Forecasting | 1 | 1997 | 2951 | 0.020 |
Why?
|
| Complement Factor I | 1 | 1987 | 14 | 0.020 |
Why?
|
| Prenylation | 1 | 2007 | 37 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 1338 | 0.020 |
Why?
|
| Receptor, TIE-2 | 1 | 2008 | 178 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1504 | 0.020 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2007 | 36 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 281 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2008 | 215 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 11124 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2001 | 12245 | 0.020 |
Why?
|
| Aortic Aneurysm | 1 | 1992 | 643 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2002 | 853 | 0.020 |
Why?
|
| Polymers | 2 | 2004 | 1621 | 0.020 |
Why?
|
| Motor Activity | 1 | 2017 | 2714 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1992 | 1475 | 0.020 |
Why?
|
| Appetite | 1 | 2009 | 243 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1988 | 821 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 2008 | 281 | 0.020 |
Why?
|
| Periodicity | 1 | 1989 | 363 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 1856 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 944 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 1869 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2007 | 157 | 0.020 |
Why?
|
| Electroporation | 1 | 2008 | 251 | 0.020 |
Why?
|
| Thrombin | 1 | 1989 | 598 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2009 | 563 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1547 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 2008 | 374 | 0.020 |
Why?
|
| Doxycycline | 1 | 2008 | 326 | 0.020 |
Why?
|
| Phagocytosis | 2 | 2003 | 1539 | 0.020 |
Why?
|
| Glycolysis | 1 | 2011 | 827 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 11727 | 0.020 |
Why?
|
| Cause of Death | 1 | 1997 | 3584 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1998 | 3176 | 0.020 |
Why?
|
| Histones | 1 | 2017 | 2599 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2006 | 22 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2009 | 381 | 0.020 |
Why?
|
| Lactones | 1 | 2009 | 329 | 0.020 |
Why?
|
| Recurrence | 2 | 2016 | 8340 | 0.020 |
Why?
|
| Hindlimb | 1 | 2008 | 504 | 0.020 |
Why?
|
| Cyanogen Bromide | 1 | 1985 | 73 | 0.020 |
Why?
|
| Piperidines | 1 | 2014 | 1602 | 0.020 |
Why?
|
| DNA Replication | 1 | 2013 | 1399 | 0.020 |
Why?
|
| Cofilin 1 | 1 | 2005 | 14 | 0.020 |
Why?
|
| Cloning, Organism | 1 | 2006 | 54 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2007 | 458 | 0.020 |
Why?
|
| Chymotrypsin | 1 | 1985 | 149 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 1985 | 173 | 0.020 |
Why?
|
| Fluorometry | 1 | 1985 | 106 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2012 | 961 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2007 | 449 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 2252 | 0.020 |
Why?
|
| Bronchi | 1 | 2009 | 840 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2008 | 449 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 1985 | 354 | 0.020 |
Why?
|
| Hypergammaglobulinemia | 1 | 1985 | 74 | 0.020 |
Why?
|
| Serine | 1 | 2009 | 826 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 3086 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2010 | 3913 | 0.020 |
Why?
|
| Cytosol | 1 | 2008 | 901 | 0.020 |
Why?
|
| Software | 1 | 2019 | 4443 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1998 | 3848 | 0.020 |
Why?
|
| Sepsis | 1 | 1999 | 2593 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 987 | 0.020 |
Why?
|
| Bacteremia | 1 | 1992 | 962 | 0.020 |
Why?
|
| Research Design | 1 | 2021 | 5987 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2002 | 4838 | 0.020 |
Why?
|
| Tuberculosis | 1 | 1998 | 1912 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2013 | 1581 | 0.020 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2004 | 28 | 0.020 |
Why?
|
| Toll-Like Receptor 10 | 1 | 2004 | 12 | 0.020 |
Why?
|
| Mass Screening | 1 | 2020 | 5255 | 0.020 |
Why?
|
| Vitamin D | 1 | 1998 | 3223 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 1988 | 707 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1114 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1985 | 549 | 0.020 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 171 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1791 | 0.020 |
Why?
|
| Thorax | 1 | 1987 | 547 | 0.020 |
Why?
|
| Receptors, Epoprostenol | 1 | 2004 | 12 | 0.020 |
Why?
|
| Cell Shape | 1 | 2005 | 375 | 0.020 |
Why?
|
| Aziridines | 1 | 2004 | 21 | 0.020 |
Why?
|
| Epoxide Hydrolases | 1 | 2005 | 122 | 0.020 |
Why?
|
| Patient Discharge | 1 | 1997 | 3313 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 2013 | 1153 | 0.020 |
Why?
|
| Cricetinae | 1 | 1988 | 2472 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2014 | 4199 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2005 | 505 | 0.020 |
Why?
|
| Integrin alpha2beta1 | 1 | 2003 | 17 | 0.010 |
Why?
|
| Cyclin A | 1 | 2004 | 60 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1989 | 1124 | 0.010 |
Why?
|
| Chromatin | 1 | 2016 | 2934 | 0.010 |
Why?
|
| Vasodilation | 1 | 2008 | 944 | 0.010 |
Why?
|
| Dendritic Spines | 1 | 2005 | 233 | 0.010 |
Why?
|
| Infusions, Intravenous | 2 | 2002 | 2274 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 2005 | 272 | 0.010 |
Why?
|
| Plasmids | 1 | 1989 | 2307 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1994 | 2585 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2004 | 624 | 0.010 |
Why?
|
| Escherichia coli | 4 | 1997 | 4217 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2000 | 2557 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2003 | 356 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 554 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 431 | 0.010 |
Why?
|
| Stem Cell Factor | 1 | 2003 | 219 | 0.010 |
Why?
|
| Bone Marrow | 2 | 2008 | 2948 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 1990 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2004 | 367 | 0.010 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2003 | 107 | 0.010 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2004 | 319 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2006 | 881 | 0.010 |
Why?
|
| Catalysis | 1 | 2004 | 761 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2007 | 1460 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2013 | 9959 | 0.010 |
Why?
|
| ADAM Proteins | 1 | 2004 | 243 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2003 | 227 | 0.010 |
Why?
|
| Paraproteinemias | 1 | 1985 | 246 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 2004 | 286 | 0.010 |
Why?
|
| Cattle | 1 | 1988 | 3922 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 1622 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2004 | 274 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2004 | 371 | 0.010 |
Why?
|
| Topotecan | 1 | 2002 | 137 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2008 | 1814 | 0.010 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2002 | 102 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 513 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1987 | 2242 | 0.010 |
Why?
|
| Aspirin | 1 | 2014 | 3282 | 0.010 |
Why?
|
| Africa, Western | 1 | 2001 | 154 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2003 | 463 | 0.010 |
Why?
|
| Gliosis | 1 | 2002 | 245 | 0.010 |
Why?
|
| Glucose | 1 | 2013 | 4397 | 0.010 |
Why?
|
| Fibrosis | 1 | 2008 | 2029 | 0.010 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2002 | 121 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2013 | 3743 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3610 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 462 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1997 | 13989 | 0.010 |
Why?
|
| Leucine | 1 | 2002 | 561 | 0.010 |
Why?
|
| DNA, Single-Stranded | 2 | 1992 | 354 | 0.010 |
Why?
|
| Triglycerides | 1 | 2008 | 2454 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2001 | 390 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2000 | 149 | 0.010 |
Why?
|
| Phalloidine | 1 | 1999 | 21 | 0.010 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2003 | 544 | 0.010 |
Why?
|
| Receptors, Vitronectin | 1 | 2000 | 52 | 0.010 |
Why?
|
| Vinculin | 1 | 2000 | 62 | 0.010 |
Why?
|
| Bronchodilator Agents | 1 | 2003 | 502 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 2004 | 696 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 2002 | 400 | 0.010 |
Why?
|
| Maximum Tolerated Dose | 1 | 2002 | 892 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1985 | 685 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 2000 | 169 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2004 | 721 | 0.010 |
Why?
|
| Risk | 2 | 2006 | 9687 | 0.010 |
Why?
|
| Biological Evolution | 2 | 1998 | 1076 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2002 | 565 | 0.010 |
Why?
|
| Tensile Strength | 1 | 2000 | 335 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2002 | 769 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1989 | 3420 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 2000 | 318 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 1998 | 93 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2003 | 793 | 0.010 |
Why?
|
| Growth Cones | 1 | 1999 | 117 | 0.010 |
Why?
|
| Osteopontin | 1 | 2000 | 296 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 1997 | 70 | 0.010 |
Why?
|
| Anxiety | 1 | 2012 | 4297 | 0.010 |
Why?
|
| Growth Plate | 1 | 2000 | 274 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1999 | 438 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1997 | 68 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2002 | 912 | 0.010 |
Why?
|
| Sphingosine | 1 | 2000 | 307 | 0.010 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2001 | 266 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1997 | 326 | 0.010 |
Why?
|
| Phospholipase C gamma | 1 | 1998 | 128 | 0.010 |
Why?
|
| Genes, Protozoan | 1 | 1998 | 163 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 428 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1998 | 232 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2002 | 1654 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2005 | 1695 | 0.010 |
Why?
|
| Mannose-Binding Lectins | 1 | 1998 | 100 | 0.010 |
Why?
|
| Microinjections | 1 | 1998 | 327 | 0.010 |
Why?
|
| Biological Transport | 1 | 2002 | 2118 | 0.010 |
Why?
|
| Endocytosis | 1 | 2002 | 985 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1997 | 347 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 1708 | 0.010 |
Why?
|
| Nerve Net | 1 | 2009 | 2174 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 242 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 1997 | 245 | 0.010 |
Why?
|
| Structure-Activity Relationship | 2 | 1995 | 3129 | 0.010 |
Why?
|
| Homeostasis | 1 | 2008 | 3340 | 0.010 |
Why?
|
| Safety | 1 | 2002 | 1186 | 0.010 |
Why?
|
| Destrin | 1 | 1996 | 9 | 0.010 |
Why?
|
| CapZ Actin Capping Protein | 1 | 1996 | 11 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1999 | 15295 | 0.010 |
Why?
|
| Melanoma | 3 | 2008 | 5510 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2004 | 12026 | 0.010 |
Why?
|
| Obesity | 2 | 2009 | 12745 | 0.010 |
Why?
|
| Calcinosis | 1 | 2005 | 1499 | 0.010 |
Why?
|
| Melanoma-Specific Antigens | 1 | 1996 | 80 | 0.010 |
Why?
|
| Ion Transport | 1 | 1997 | 320 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 494 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2000 | 547 | 0.010 |
Why?
|
| Hexamethonium Compounds | 1 | 1976 | 23 | 0.010 |
Why?
|
| Protein Transport | 1 | 2002 | 1988 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1998 | 316 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1997 | 1157 | 0.010 |
Why?
|
| Receptors, Thrombin | 1 | 1996 | 131 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 7149 | 0.010 |
Why?
|
| Bone Resorption | 1 | 2000 | 723 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 2061 | 0.010 |
Why?
|
| Models, Molecular | 2 | 2000 | 5456 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 1995 | 80 | 0.010 |
Why?
|
| Epithelium | 1 | 2000 | 1679 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1997 | 1095 | 0.010 |
Why?
|
| Bacteriophage P1 | 1 | 1995 | 10 | 0.010 |
Why?
|
| Chromosome Walking | 1 | 1995 | 27 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2003 | 2765 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2002 | 2234 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1995 | 94 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1995 | 118 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2000 | 1355 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2009 | 6256 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 1996 | 25043 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 6993 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 6489 | 0.010 |
Why?
|
| Injections | 1 | 1997 | 840 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1996 | 590 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2003 | 1912 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2002 | 2309 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1997 | 514 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 23338 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2003 | 2072 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 2001 | 1094 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2008 | 4043 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1995 | 376 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 2513 | 0.010 |
Why?
|
| Insect Vectors | 1 | 1994 | 134 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 3772 | 0.010 |
Why?
|
| HIV Infections | 1 | 1999 | 16718 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1992 | 75 | 0.010 |
Why?
|
| Agglutination Tests | 1 | 1992 | 41 | 0.010 |
Why?
|
| Peptide Fragments | 3 | 1992 | 5097 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1995 | 648 | 0.010 |
Why?
|
| Glucosides | 1 | 1996 | 451 | 0.010 |
Why?
|
| Europe, Eastern | 1 | 1992 | 75 | 0.010 |
Why?
|
| Gene Library | 1 | 1994 | 1074 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1997 | 1609 | 0.010 |
Why?
|
| Epitopes | 1 | 1998 | 2571 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 7181 | 0.010 |
Why?
|
| Polymyxin B | 1 | 1990 | 46 | 0.010 |
Why?
|
| Fibroma | 1 | 1992 | 212 | 0.010 |
Why?
|
| Ligands | 1 | 1998 | 3282 | 0.010 |
Why?
|
| Chimera | 1 | 1992 | 485 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1997 | 1813 | 0.010 |
Why?
|
| Aging | 1 | 2009 | 8664 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1990 | 263 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1998 | 2187 | 0.010 |
Why?
|
| Neutropenia | 1 | 1995 | 895 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1995 | 1420 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1995 | 2971 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1997 | 4933 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 1998 | 1940 | 0.010 |
Why?
|
| Solubility | 1 | 1990 | 1085 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1991 | 1681 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2000 | 3279 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1990 | 1454 | 0.000 |
Why?
|
| Endothelium | 1 | 1990 | 778 | 0.000 |
Why?
|
| Molecular Structure | 1 | 1992 | 1899 | 0.000 |
Why?
|
| Thrombocytopenia | 1 | 1995 | 1179 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1988 | 919 | 0.000 |
Why?
|
| Postoperative Period | 1 | 1992 | 1842 | 0.000 |
Why?
|
| Probability | 1 | 1992 | 2505 | 0.000 |
Why?
|
| Interleukin-1beta | 1 | 1992 | 972 | 0.000 |
Why?
|
| Blood Specimen Collection | 1 | 1988 | 246 | 0.000 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2003 | 5442 | 0.000 |
Why?
|
| Placenta | 1 | 1994 | 1698 | 0.000 |
Why?
|
| Shock, Septic | 1 | 1992 | 775 | 0.000 |
Why?
|
| Sural Nerve | 1 | 1985 | 106 | 0.000 |
Why?
|
| Random Allocation | 1 | 1989 | 2429 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 8037 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1985 | 218 | 0.000 |
Why?
|
| Tropomyosin | 1 | 1985 | 102 | 0.000 |
Why?
|
| Seasons | 1 | 1990 | 1493 | 0.000 |
Why?
|
| Deoxyribonuclease I | 1 | 1985 | 229 | 0.000 |
Why?
|
| Reference Standards | 1 | 1988 | 1025 | 0.000 |
Why?
|
| Vitamin D-Binding Protein | 1 | 1985 | 129 | 0.000 |
Why?
|
| Myosins | 1 | 1985 | 409 | 0.000 |
Why?
|
| Peptides | 1 | 1995 | 4409 | 0.000 |
Why?
|
| Heart Failure | 1 | 2006 | 10900 | 0.000 |
Why?
|
| Fasting | 1 | 1988 | 1593 | 0.000 |
Why?
|
| Eating | 1 | 1988 | 1536 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15165 | 0.000 |
Why?
|
| Spinal Cord | 1 | 1985 | 1809 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1992 | 8554 | 0.000 |
Why?
|